| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787463 | Journal of the Egyptian National Cancer Institute | 2018 | 6 Pages |
Abstract
A very high rate of survival is currently achievable in patients with intermediate risk neuroblastoma by chemotherapy or chemotherapy and surgery. In addition to response, our plan is to adopt biologically-based treatment to reduce treatment-induced complications among survivors.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hossam Elzomor, Gehad Ahmed, Salma Elmenawi, Naglaa Elkinaai, Amal Refaat, Sonya Soliman, Mai Amr Abdelwahab, Mohamed Saad Zaghloul, Mohamed Fawzy,